Live birth after treatment of severe adenomyosis with a gonadotropin-releasing hormone agonist

P. D. Silva, Silva PD, H E Perkins, Perkins HE, C W Schauberger, Schauberger CW
Fertility and sterility · 1994 · doi:10.1016/s0015-0282(16)56471-1 · PMID:8293832
case-report OA: closed public-domain-us
View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-29 ⓘ

A woman with severe adenomyosis conceived and delivered a healthy baby shortly after stopping GnRH-agonist therapy, representing the first reported live birth following such treatment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A patient with a 10-year history of secondary infertility underwent GnRH-a therapy with LA for 5 months to control symptoms of severe adenomyosis and to avoid an unwanted hysterectomy. Shortly after cessation of treatment, the patient conceived. A healthy male was delivered at term by cesarean section, which makes this the first report of a live birth after treatment of severe adenomyosis with a GnRH-a.

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosisinfertility

MeSH descriptors

Endometriosis Leuprolide Pregnancy Outcome Uterine Diseases Adult Endometriosis Endometriosis Female Humans Infertility, Female Infertility, Female Injections, Intramuscular Leuprolide Leuprolide Pregnancy Treatment Outcome Ultrasonography Uterine Diseases Uterine Diseases Uterus

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

europepmc
last seen: 2026-08-16T09:21:09.727480+00:00
pubmed
last seen: 2026-05-13T22:11:29.222973+00:00
unpaywall
last seen: 2026-08-16T06:22:10.609676+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine